Researchers from Manchester and Melbourne assess the impact of high drop-out rates on Cochrane reviews of five frequently prescribed second-generation antipsychotics. They found that all five reviews misrepresented the available evidence by including data from studies with unacceptable levels of attrition, often without any acknowledgment or justification. Results will appear in Acta Psychiatrica Scandinavica.
Article →
***
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
***
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.
